Success Stories: Our Team Acquires NIW Approval for a Research Scientist from Nepal with 5 Major International Research Fundings

Client’s Testimonial:

“Thank you very much for the I-140 approval information. The service from Wegreened was fantastic and we appreciate all of your efforts to make this successful.”

On March 7^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Synthetic Chemistry (Approval Notice).

General Field: Synthetic Chemistry

Position at the Time of Case Filing: Research Scientist

Country of Origin: Nepal

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: March 7^th, 2022

Processing Time: 9 months, 17 days

Case Summary:

A research scientist in the field of synthetic chemistry from Nepal proposed an endeavor to continue his research on developing new chemical reactions for shortening synthetic routes, improving molecular complexity, and reducing overall cost when developing drug therapies to treat cancer and other diseases. So, it was clear that his research was very important because it advances the development of vital new drugs. This is why when he approached us for his NIW (National Interest Waiver) case, our team quickly aided him in preparing his case proving that his work was in the national interest. This was made possible by adding the following information:

His work has resulted in 6 peer-reviewed journal articles (3 of them first-authored) and 1 international patent application.
These publications have been cited a total of 31 times, according to Google Scholar.
Evidence of his major international and national funding sources namely the National Institute of General Medical Sciences, the European Community’s Seventh Framework Program, the German Research Foundation, the National Institutes of Health, and the National Science Foundation.
His expert status in the field is further confirmed by his appointment as a referee for peer-reviewed journals and conferences. He has conducted reviews for highly acclaimed journals. Therefore, his role as a peer reviewer proves he is an authority in the field.
We also illustrated these facts through testimonials collected from 5 experts in the field who wrote letters of recommendation in his favor. One such testimonial is shown below:

“[The client] is working to actively combat cancer as a synthetic organic and medicinal chemist studying the structure-activity relationships of proteasome inhibitors, which are known for their anticancer effects. Specifically, [client’s] research on the synthesis and evaluation of proteasome inhibitors have expanded the field’s capability to use these materials for the production of more effective cancer pharmaceuticals. Given the broad significance of public health, [client’s] work is of immense value to millions of people worldwide.”

We are extremely happy that our team could help our client prove his research, which is relevant to the improvement of anticancer drugs, reducing the death rate and economic burden associated with cancer, and enhancing pharmaceuticals for the treatment of a variety of illnesses. Thus, when the approval for this case arrived from USCIS, our team rejoiced in the victory. We are glad to share in the success of our client, and we wish him the best.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.